Cargando…

Cholangiopathy with Respect to Biliary Innate Immunity

Biliary innate immunity is involved in the pathogenesis of cholangiopathies in cases of biliary disease. Cholangiocytes possess Toll-like receptors (TLRs) which recognize pathogen-associated molecular patterns (PAMPs) and play a pivotal role in the innate immune response. Tolerance to bacterial PAMP...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kenichi, Nakanuma, Yasuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168927/
https://www.ncbi.nlm.nih.gov/pubmed/21994888
http://dx.doi.org/10.1155/2012/793569
_version_ 1782211447345905664
author Harada, Kenichi
Nakanuma, Yasuni
author_facet Harada, Kenichi
Nakanuma, Yasuni
author_sort Harada, Kenichi
collection PubMed
description Biliary innate immunity is involved in the pathogenesis of cholangiopathies in cases of biliary disease. Cholangiocytes possess Toll-like receptors (TLRs) which recognize pathogen-associated molecular patterns (PAMPs) and play a pivotal role in the innate immune response. Tolerance to bacterial PAMPs such as lipopolysaccharides is also important to maintain homeostasis in the biliary tree, but tolerance to double-stranded RNA (dsRNA) is not found. Moreover, in primary biliary cirrhosis (PBC) and biliary atresia, biliary innate immunity is closely associated with the dysregulation of the periductal cytokine milieu and the induction of biliary apoptosis and epithelial-mesenchymal transition (EMT), forming in disease-specific cholangiopathy. Biliary innate immunity is associated with the pathogenesis of various cholangiopathies in biliary diseases as well as biliary defense systems.
format Online
Article
Text
id pubmed-3168927
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31689272011-10-12 Cholangiopathy with Respect to Biliary Innate Immunity Harada, Kenichi Nakanuma, Yasuni Int J Hepatol Review Article Biliary innate immunity is involved in the pathogenesis of cholangiopathies in cases of biliary disease. Cholangiocytes possess Toll-like receptors (TLRs) which recognize pathogen-associated molecular patterns (PAMPs) and play a pivotal role in the innate immune response. Tolerance to bacterial PAMPs such as lipopolysaccharides is also important to maintain homeostasis in the biliary tree, but tolerance to double-stranded RNA (dsRNA) is not found. Moreover, in primary biliary cirrhosis (PBC) and biliary atresia, biliary innate immunity is closely associated with the dysregulation of the periductal cytokine milieu and the induction of biliary apoptosis and epithelial-mesenchymal transition (EMT), forming in disease-specific cholangiopathy. Biliary innate immunity is associated with the pathogenesis of various cholangiopathies in biliary diseases as well as biliary defense systems. Hindawi Publishing Corporation 2012 2011-08-11 /pmc/articles/PMC3168927/ /pubmed/21994888 http://dx.doi.org/10.1155/2012/793569 Text en Copyright © 2012 K. Harada and Y. Nakanuma. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Harada, Kenichi
Nakanuma, Yasuni
Cholangiopathy with Respect to Biliary Innate Immunity
title Cholangiopathy with Respect to Biliary Innate Immunity
title_full Cholangiopathy with Respect to Biliary Innate Immunity
title_fullStr Cholangiopathy with Respect to Biliary Innate Immunity
title_full_unstemmed Cholangiopathy with Respect to Biliary Innate Immunity
title_short Cholangiopathy with Respect to Biliary Innate Immunity
title_sort cholangiopathy with respect to biliary innate immunity
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168927/
https://www.ncbi.nlm.nih.gov/pubmed/21994888
http://dx.doi.org/10.1155/2012/793569
work_keys_str_mv AT haradakenichi cholangiopathywithrespecttobiliaryinnateimmunity
AT nakanumayasuni cholangiopathywithrespecttobiliaryinnateimmunity